Event-Driven Stocks

SEELOS THERAPEUTICS, INC.

Healthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕

Signs● 2 good● 4 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY23FY22FY21FY20FY19FY18
Revenue$2.2M——$0$375,000$0
Operating income−$40.5M−$70.9M−$61.7M−$18.8M−$29.7M−$3.2M
Net income−$37.9M−$73.5M−$66.0M−$19.1M−$51.3M−$3.5M
Total assets$5.4M$22.7M$83.5M$17.5M$11.1M$191,000
Total liabilities$38.9M$33.4M$26.2M$14.9M$11.1M$4.9M
Equity−$33.5M−$10.6M$57.3M$2.6M−$7,000−$4.7M
EPS (diluted)$-7.73$-20.74$-0.73———
Shares out.108.1M105.5M73.2M36.5M18.4M16.3M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2023
Operating margin
−1838.4%
Net margin
−1719.6%
Return on equity
113.0%
Return on assets
−699.2%
Return on capital (ROCE)
—
Liabilities / assets
718.5%
Debt / equity
—
Book value / share
$-0.31
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2023
Altman Z″ (distress)
-243.73distress
Accruals / assets
−257.8%clean
Piotroski F-Score
1/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
31
/ 100
Profitability 25Growth n/aCatalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 4 warning● 2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)